NCT04446585

Cardiac Arrest in Residential Areas With Mobile First-responder Activation

A Cluster Randomized Clinical Trial of Strategic AED Deployment in High-risk Residential Areas Combined With Activation of Local Residents

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 260 (estimated)
• Sponsor: Emergency Medical Services, Capital Region, Denmark · Other Government
• Sex: All
• Age: 8 Years
• Healthy volunteers: Not accepted

Summary

The study aims to increase proportions of bystander defibrillation during out-of-hospital cardiac arrest (hereof referred to as cardiac arrest) in residential areas with a high density of cardiac arrests. The intervention consists of Automated External Defibrillators (AEDs) and residents' involvement in resuscitation through training and enrollment as citizen responders.

Detailed description

Survival decreases by 10% for every minute that passes after a cardiac arrest until defibrillation. Despite an increasing number of available AEDs, survival and defibrillation rates in residential areas remain poor. Efforts to increase bystander defibrillation has the potential to improve survival. Through the strategic deployment of AEDs, training, and recruitment of residents as citizen responders, we aim to improve proportions of bystander defibrillation and 30-day survival in densely populated residential areas with a high density of cardiac arrests.

Conditions

• Out-Of-Hospital Cardiac Arrest

Interventions

Type	Name	Description
DEVICE	Automated External Defibrillator (AED)	Deployment of AEDs
OTHER	Training in cardiopulmonary resuscitation and AED use	Residents will undergo 30-minute courses at study start and if needed during the trial period. During the course they will also be recruited as citizen responders
OTHER	Activation of citizen responders	Citizen responders will be activated in case of suspected cardiac arrest through the heart runner app.

Timeline

• Start date: 2021-12-01
• Primary completion: 2027-01-01
• Completion: 2027-01-01
• First posted: 2020-06-25
• Last updated: 2023-09-15

Locations

1 site across 1 country: Denmark

Regulatory

• FDA-regulated device study